The study further showed that knockdown of SIRT1 or PGC1α sensitized the tumour cells to the drug treatment, suggesting that the SIRT1/PGC1α is a novel pathway of drug resistance that may be targeted for therapy. This evidence concerns the gene PPARGC1A and neoplasm.